Cambridge, United States
ProFound Therapeutics
$35.0M
startup
Summary
ProFound Therapeutics received an investment commitment of up to $35 million from the Gates Foundation, including an initial $20 million investment. The funding supports the company’s work on new solutions for women’s health and on preeclampsia and eclampsia. ProFound Therapeutics is a biotechnology company developing first-in-class medicines from the expanded human proteome.